View of Cost-effectiveness analysis of EGFR-TKIS for the treatment of EGFR mutation-positive non-small cell lung cancer

Return to Article Details Cost-effectiveness analysis of EGFR-TKIS for the treatment of EGFR mutation-positive non-small cell lung cancer Download Download PDF